Keros Therapeutics, Inc. (KROS)
19.53
+0.03
(+0.15%)
USD |
NASDAQ |
Jan 14, 16:00
19.53
0.00 (0.00%)
After-Hours: 19:51
Keros Therapeutics Price: 19.53 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1074.00 |
| Pfizer Inc. | 25.58 |
| Innoviva, Inc. | 19.74 |
| Ocugen, Inc. | 1.875 |
| Bionano Genomics, Inc. | 1.56 |
Price Related Metrics
| PE Ratio | 12.66 |
| PS Ratio | 3.218 |
| Price to Book Value | 0.8457 |
| Price to Free Cash Flow | 9.116 |
| Earnings Yield | 7.90% |
| Market Cap | 595.00M |
| Operating PE Ratio | 18.21 |
| Normalized PE Ratio | 12.66 |